ENROBAGE DES COMPRIMS PDF

Faujin A tablet according to claim 2, characterized in that the acrylic polymer is Eudragit type. Galenical forms for the sustained release of verapamil, their preparation and medicaments containing them. New tablets and new composition for the treatment of cerebral circulatory system disorder, and their preparation. Programmed-release tablet of water-soluble salt s of cinepazide and process for preparing it.

Author:Gosida Fetaur
Country:Nigeria
Language:English (Spanish)
Genre:Love
Published (Last):13 July 2018
Pages:176
PDF File Size:13.34 Mb
ePub File Size:1.44 Mb
ISBN:123-7-38787-931-9
Downloads:12584
Price:Free* [*Free Regsitration Required]
Uploader:Aralabar



Gardajin A method according to any one of claims 1 to 8, characterized in that the tablet comprises, as an excipient, one or more substances selected from the group comprising saccharose, sorbitol, lactose, calcium phosphate, various forms cellulose, citric acid, tartaric acid, sodium bicarbonate, lysine carbonate, ascorbic acid and derivatives thereof, tocopherols, methyl and propylparabens, sorbic acid and its salts, oxide colloidal aluminum, magnesium stearate, calcium, sodium lauryl sulfate, silicone oil and paraffin oil.

Pharmaceutical tablets for easy administration of pellets, their preparation and use. A tablet according to any one of claims 1 to 8, characterized in that it comprises, as an excipient, one or more substances selected from the group comprising saccharose, sorbitol, lactose, calcium phosphate, various forms cellulose, citric acid, tartaric acid, sodium bicarbonate, lysine carbonate, ascorbic acid and derivatives thereof, tocopherols, methyl and propylparabens, sorbic acid and its salts, oxide colloidal aluminum, magnesium stearate, calcium, sodium lauryl sulfate, silicone oil and paraffin oil.

Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water. Programmed-release tablet of water-soluble salt s of cinepazide and process for preparing it. A process according to any of claims 1 to 3, characterized in that the hydrophilic substance is constituted by a cellulose derivative or a mixture of such derivatives.

Method of use of the tablet according to any one of claims 1 to 12, characterized in that the oral route is administered by said tablet containing a thera- peutiquement effective amount of active ingredient, in whole or in the form of one or more fragments thereof. A tablet according to claim 2, characterized in that the acrylic polymer is Eudragit type. Process for the preparation of small controlled release particles with a high content of Etofibrat, its use and its orally administrable forms.

A process according to any of claims 1 to 7, characterized in that the tablet comprises, on one face at least one groove that guides its fractionation. A tablet enrpbage to any one of claims 1 to 11, characterized in that the matrix comprises between New tablets and new composition for the treatment of cerebral circulatory system disorder, and their preparation. The pharmaceutical tablets are of the sustained-release type, the matrix of which, constituting the body of the tablets, comprises a mixture of at least one pharmacologically acceptable inert substance with at least one pharmacologically acceptable hydrophilic substance.

A tablet according to any one of claims enobage to 5, characterized in that the dees ratio of the inert substance in relation to the hydrophilic substance is of the order of 0. Comme excipients pharmlceutiquement acceptables, on put citer — des diluants, solubles ou insolubles, comn par exemple, le saccharose, le sorbitol, le lactose, le phosphate calcique, diverses formes de cellulose.

Tablets Pharmaceutical has sustained release, their preparation and their use. Aqueous polymeric dispersion of cellulosic and acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof.

A process according to any of claims 1 to 9, characterized in that the tablet comprises, as active ingredient, one or more enrobabe selected from the group dew of the xanthine derivatives, antiinflammatories, P-blockers, calcium channel blockersantiepileptics, benzodiazepines, diuretics, analgesics, hormones and antidepressants. Pharmaceutical anti-tuberculosis composition and method intended to produce said composition. A tablet according to any one of claims 1 to 7, characterized in that it comprises on one of its faces at least one groove that guides its fractionation.

A process according to any of claims 1 to 11, characterized in that the matrix comprises between Coating composition for ces masking coating and methods for their application and use. Pharmaceutical compositions containing trapidil, and process for their preparation.

A tablet according to any one of claims 1 to 3, characterized in that the hydrophilic substance is constituted by a cellulose derivative or comproms mixture that such derivatives. A3 Designated state s: Galenical forms of verapamil, preparation thereof and medicaments containing them. Process for preparing the tablet according to any one of claims 1 to 12, characterized in that one mixes the active ingredient, matrix and binding agent, sieved, granulated optionally caliber granulated and compresses to obtain a desired tablet weight and hardness.

A process for preparing a pharmaceutical tablet of the sustained release type, characterized in that one mixes the active ingredient, the body of the tablet comprising a mixture of at least one inert substance with at least one pharmacologically acceptable hydrophilic substance and excipient, sieved, granulated optionally releases the granules and compressed to give a tablet weight and hardness desired. Tablets for controlled release of 4-amino-salicylic acid — has hydrophilic matrix and enteric coating, for treating intestinal inflammation.

Kind comprins of ref document: Method according to Claim 1, characterized in that the inert material is constituted by an acrylic polymer or a mixture of such polymers.

A pharmaceutical tablet of the sustained release type, characterized in that the matrix forming dse body of the tablet comprises a mixture of at least one inert substance with at least one pharmacologically acceptable hydrophilic substance.

Galenical forms for the sustained release of verapamil, their preparation and medicaments containing them. A tablet according to claim 1, characterized in that the inert material is constituted by an acrylic polymer or a mixture of such polymers.

Related Posts

ADELE CLARKE SITUATIONAL ANALYSIS PDF

Dosage de solides

.

COMPLETE ACOA SOURCEBOOK PDF

.

Related Articles